Literature DB >> 20479525

Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects cortical neurons from dying following a traumatic brain injury.

Jennie E Minnich1, Sarah L Mann, Megan Stock, Kathryn A Stolzenbach, Bridget M Mortell, Katherine E Soderstrom, Martha C Bohn, Dorothy A Kozlowski.   

Abstract

PURPOSE: The therapeutic potential of glial cell line-derived neurotrophic factor (GDNF) gene delivery was examined in a rodent model of traumatic brain injury (TBI), the controlled cortical impact (CCI).
METHODS: An adenoviral vector harboring human GDNF (AdGDNF) or green fluorescent protein (AdGFP) was injected unilaterally into the forelimb sensorimotor cortex (FL-SMC) of the rat one week prior to a unilateral CCI. Tests of forelimb function and asymmetry were administered for 2 weeks post-injury. At 2 weeks post-injury, animals were sacrificed and contusion size, neuronal survival, neurodegeneration, and virally-mediated GDNF and GFP protein expression were measured.
RESULTS: Rats injected with AdGDNF had significantly smaller contusions, more surviving neurons, and less neurodegeneration than AdGFP injected and uninjected injured animals. GDNF gene delivery also resulted in significantly faster recovery of forelimb coordination and a smaller initial preference for the uninjured forelimb during exploration of the walls of a platform. However, overall recovery of symmetrical forelimb use was not achieved.
CONCLUSIONS: The discrepancy between neural protection and behavioral recovery suggests that while GDNF gene delivery provided a high degree of protection of damaged cortical neurons in this model of TBI, it may not have fully protected their terminals and synaptic functioning, resulting in only mild protection against behavioral deficits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20479525     DOI: 10.3233/RNN-2010-0528

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  17 in total

Review 1.  Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?

Authors:  Anthony E Kline; Jacob B Leary; Hannah L Radabaugh; Jeffrey P Cheng; Corina O Bondi
Journal:  Prog Neurobiol       Date:  2016-05-07       Impact factor: 11.685

2.  Combining glial cell line-derived neurotrophic factor gene delivery (AdGDNF) with L-arginine decreases contusion size but not behavioral deficits after traumatic brain injury.

Authors:  M L Degeorge; D Marlowe; E Werner; K E Soderstrom; M Stock; A Mueller; M C Bohn; D A Kozlowski
Journal:  Brain Res       Date:  2011-06-02       Impact factor: 3.252

3.  Methylation status of promoter 1 region of GDNF gene in human glioma cells.

Authors:  Maohua Chen; Zhenghao Liu; Yuefei Deng; Xianglin Chen; Jianmin Zhang
Journal:  Int J Clin Exp Med       Date:  2014-07-15

Review 4.  Growth factor therapy sequesters inflammation in affording neuroprotection in cerebrovascular diseases.

Authors:  Hung Nguyen; David Aum; Sherwin Mashkouri; Gautam Rao; Juan Diego Vega Gonzales-Portillo; Stephanny Reyes; Cesario V Borlongan
Journal:  Expert Rev Neurother       Date:  2016-05-13       Impact factor: 4.618

5.  Neuroprotective effects of GDNF-expressing human amniotic fluid cells.

Authors:  Anna Jezierski; Kerry Rennie; Bogdan Zurakowski; Maria Ribecco-Lutkiewicz; Julie Haukenfrers; Abdellah Ajji; Andrée Gruslin; Marianna Sikorska; Mahmud Bani-Yaghoub
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

6.  Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture.

Authors:  Eric Wildon Kostuk; Jingli Cai; Lorraine Iacovitti
Journal:  Glia       Date:  2019-04-26       Impact factor: 7.452

7.  Zirconium oxide ceramic foam: a promising supporting biomaterial for massive production of glial cell line-derived neurotrophic factor.

Authors:  Zhong-wei Liu; Wen-qiang Li; Jun-kui Wang; Xian-cang Ma; Chen Liang; Peng Liu; Zheng Chu; Yong-hui Dang
Journal:  J Zhejiang Univ Sci B       Date:  2014-12       Impact factor: 3.066

8.  Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat.

Authors:  Daniel R van Bregt; Theresa Currier Thomas; Jason M Hinzman; Tuoxin Cao; Mei Liu; Guoying Bing; Greg A Gerhardt; James R Pauly; Jonathan Lifshitz
Journal:  Exp Neurol       Date:  2011-12-09       Impact factor: 5.330

9.  Neuroprotective Effect of Artesunate in Experimental Model of Traumatic Brain Injury.

Authors:  Enrico Gugliandolo; Ramona D'Amico; Marika Cordaro; Roberta Fusco; Rosalba Siracusa; Rosalia Crupi; Daniela Impellizzeri; Salvatore Cuzzocrea; Rosanna Di Paola
Journal:  Front Neurol       Date:  2018-07-31       Impact factor: 4.003

10.  JM-20 Treatment After Mild Traumatic Brain Injury Reduces Glial Cell Pro-inflammatory Signaling and Behavioral and Cognitive Deficits by Increasing Neurotrophin Expression.

Authors:  Andrezza Bond Vieira Furtado; Debora Farina Gonçalves; Diane Duarte Hartmann; Aline Alves Courtes; Gustavo Cassol; Yanier Nunez-Figueredo; Deivison Silva Argolo; Ravena Pereira do Nascimento; Silvia Lima Costa; Victor Diogenes Amaral da Silva; Luiz Fernando Freire Royes; Félix Alexandre Antunes Soares
Journal:  Mol Neurobiol       Date:  2021-06-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.